Topic
Pandemic Sciences Institute
Oxford University begins first human trial of Bundibugyo Ebola vaccine
Researchers are testing the ChAdOx BDBV vaccine on 50 volunteers to address the Bundibugyo ebolavirus strain currently spreading in the DRC.